secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001213900-24-043761
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

180 Life Sciences receives Nasdaq delisting notice after failing to meet equity requirement
--------------------------------------------------------------------------------

- Company failed to regain compliance with Nasdaq's minimum $2.5M stockholders' equity by May 13, 2024 deadline.
- Received delist determination letter on May 14, 2024; trading suspension scheduled for May 23, 2024 unless appeal.
- Intends to request a hearing before Nasdaq Hearings Panel, which would stay delisting pending process.
- Also notified of non-compliance with audit committee composition (need three independent directors); cure period until May 2025.
- Common stock (ATNF) and warrants (ATNFW) will continue trading on Nasdaq pending hearing outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390024043761/0001213900-24-043761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390024043761/ea0206133-8k_180lifesci.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-043761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer